Search icon

Revitalid Pharmaceutical Corp.

Company claim

Is this your business?

Get access!

Company Details

Name: Revitalid Pharmaceutical Corp.
Jurisdiction: Rhode Island
Entity type: Foreign Corporation
Status: Revoked Entity
Date of Organization in Rhode Island: 15 Jul 2020 (5 years ago)
Date of Dissolution: 17 Sep 2024 (10 months ago)
Date of Status Change: 17 Sep 2024 (10 months ago)
Identification Number: 001710029
Place of Formation: DELAWARE
Purpose: PHARMACEUTICAL SALES
Historical names: Osmotica Pharmaceutical Corp.
Principal Address: Google Maps Logo 400 CROSSING BOULEVARD, BRIDGEWATER, NJ, 08807, USA

Agent

Name Role Address
CORPORATION SERVICE COMPANY Agent 222 JEFFERSON BOULEVARD SUITE 200, WARWICK, RI, 02888, USA

SECRETARY

Name Role Address
CHRISTOPHER KLEIN SECRETARY 400 CROSSING BLVD, BRIDGEWATER, NJ 08807 USA

CEO

Name Role Address
BRIAN MARKISON CEO 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA

CFO

Name Role Address
ANDREW EINHORN CFO 400 CROSSING BLVD, BRIDGEWATER, NJ 08807 USA

DIRECTOR

Name Role Address
BRIAN MARKISON DIRECTOR 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA
CARLOS SIELECKI DIRECTOR 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA
DANIEL SIELECKI DIRECTOR 400 CROSSING BLVD, BRIDGEWATER, NJ 08807 USA
JUAN VERGEZ DIRECTOR 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA
SRIRAM VENKATARAMAN DIRECTOR 400 CROSSING BLVD BRIDGEWATER, NJ 08807 USA
DAVID BURGSTAHLER DIRECTOR 65 EAST 55TH STREET,18TH FLOOR NEW YORK, NY 10022 USA

Events

Type Date Old Value New Value
Name Change 2023-04-18 Osmotica Pharmaceutical Corp. Revitalid Pharmaceutical Corp.

Filings

Number Name File Date
202459587510 Revocation Certificate For Failure to File the Annual Report for the Year 2024-09-17
202457269300 Revocation Notice For Failure to File An Annual Report 2024-06-25
202334284060 Annual Report 2023-04-27
202333227310 Application for Amended Certificate of Authority 2023-04-18
202218679210 Annual Report 2022-06-21

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 16 Jul 2025

Sources: Rhode Island Department of State